Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles

Pancreatic cancer remains one of the most intractable cancers, with a dismal prognosis reflected by a 5-year survival of ~6%. Since early disease symptoms are undefined and specific biomarkers are lacking, about 80% of patients present with advanced, inoperable tumors that represent a daunting chall...

Full description

Bibliographic Details
Main Authors: Victor M. Blanco, Tahir Latif, Zhengtao Chu, Xiaoyang Qi
Format: Article
Published: Elsevier 2015-06-01
Series:Translational Oncology
Online Access: